Butler, P. C., Elashoff, M., Elashoff, R., & Gale, E. A. (2013). A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe? American Diabetes Association.
Chicago ZitierstilButler, Peter C., Michael Elashoff, Robert Elashoff, und Edwin A.M Gale. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? American Diabetes Association, 2013.
MLA ZitierstilButler, Peter C., Michael Elashoff, Robert Elashoff, und Edwin A.M Gale. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? American Diabetes Association, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.